Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,976,000 | 1,801,000 | 2,018,000 | 3,050,000 | 3,680,000 |
| Marketable Securities | 289,000 | 424,000 | 1,995,000 | 2,749,000 | 3,794,000 |
| Receivables | 3,644,000 | 3,994,000 | 3,247,000 | 3,378,000 | 4,373,000 |
| Inventories | 1,765,000 | 2,162,000 | 2,079,000 | 2,060,000 | 1,830,000 |
| Income taxes - deferred | 703,000 | 851,000 | 649,000 | 776,000 | 805,000 |
| Other current assets | 0 | 560,000 | 0 | 0 | 0 |
| TOTAL | $14,697,000 | $10,102,000 | $10,302,000 | $12,283,000 | $14,801,000 |
| Non-Current Assets | |||||
| PPE Net | 5,405,000 | 5,650,000 | 5,673,000 | 5,693,000 | 5,765,000 |
| Investments And Advances | 188,000 | 0 | 0 | 0 | 0 |
| Intangibles | 5,978,000 | 6,328,000 | 6,681,000 | 6,744,000 | 7,165,000 |
| Other Non-Current Assets | 3,218,000 | 3,846,000 | 2,919,000 | 3,418,000 | 2,704,000 |
| TOTAL | $14,789,000 | $15,824,000 | $15,273,000 | $15,855,000 | $15,634,000 |
| Total Assets | $29,486,000 | $25,926,000 | $25,575,000 | $28,138,000 | $30,435,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 154,000 | 1,891,000 | 187,000 | 231,000 | 1,883,000 |
| Accounts payable and accrued liabilities | 1,535,000 | 1,442,000 | 1,239,000 | 1,579,000 | 2,127,000 |
| Accrued Expenses | 2,974,000 | 2,951,000 | 2,332,000 | 2,321,000 | 2,838,000 |
| Other current liabilities | N/A | 35,000 | N/A | N/A | N/A |
| TOTAL | $6,710,000 | $8,398,000 | $6,496,000 | $6,890,000 | $9,843,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,585,000 | 4,381,000 | 7,248,000 | 8,364,000 | 8,463,000 |
| Deferred Revenues | 277,000 | 201,000 | 411,000 | 125,000 | 32,000 |
| aiOther Non-Current Liabilities | 1,730,000 | 571,000 | 1,486,000 | 1,435,000 | 1,519,000 |
| TOTAL | $10,568,000 | $6,966,000 | $9,088,000 | $10,040,000 | $10,390,000 |
| Total Liabilities | $17,278,000 | $15,364,000 | $15,584,000 | $16,930,000 | $20,233,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,979,509 | 1,979,388 | 2,019,481 | 1,959,073 | 1,951,786 |
| Common Shares | 220,000 | 220,000 | 220,000 | 220,000 | 220,000 |
| Retained earnings | 22,549,000 | 19,762,000 | 19,845,000 | 20,464,000 | 19,651,000 |
| Other shareholders' equity | -2,752,000 | -1,558,000 | -1,773,000 | -765,000 | -849,000 |
| TOTAL | $12,208,000 | $10,562,000 | $9,991,000 | $11,208,000 | $10,202,000 |
| Total Liabilities And Equity | $29,486,000 | $25,926,000 | $25,575,000 | $28,138,000 | $30,435,000 |